Detalhe da pesquisa
1.
Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF).
Hepatology
; 79(1): 135-148, 2024 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37505221
2.
Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease.
Gut
; 73(5): 825-834, 2024 Apr 05.
Artigo
Inglês
| MEDLINE | ID: mdl-38199805
3.
Is There a Safe Alcohol Consumption Limit for the General Population and in Patients with Liver Disease?
Semin Liver Dis
; 44(1): 69-78, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38574752
4.
Artificial intelligence-assisted digital pathology for non-alcoholic steatohepatitis: current status and future directions.
J Hepatol
; 80(2): 335-351, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-37879461
5.
Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease.
J Hepatol
; 80(3): 419-430, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-37984709
6.
Predicting survival in patients with 'non-high-risk' acute variceal bleeding receiving ß-blockers+ligation to prevent re-bleeding.
J Hepatol
; 80(1): 73-81, 2024 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37852414
7.
A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH.
N Engl J Med
; 385(17): 1547-1558, 2021 10 21.
Artigo
Inglês
| MEDLINE | ID: mdl-34670042
8.
Predicting liver-related events in NAFLD: A predictive model.
Hepatology
; 78(4): 1240-1251, 2023 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36994693
9.
Risk of liver-related events in metabolic dysfunction-associated steatohepatitis (MASH) patients with fibrosis: A comparative analysis of various risk stratification criteria.
Hepatology
; 2023 Oct 02.
Artigo
Inglês
| MEDLINE | ID: mdl-37796137
10.
Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: A development and validation study.
Hepatology
; 78(1): 258-271, 2023 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36994719
11.
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.
Hepatology
; 78(6): 1966-1986, 2023 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37363821
12.
Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection and COVID-19 disease severity.
FASEB J
; 37(11): e23220, 2023 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37801035
13.
Novel insights into metabolic-associated steatotic liver disease preclinical models.
Liver Int
; 44(3): 644-662, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38291855
14.
Development and validation of an image biomarker to identify metabolic dysfunction associated steatohepatitis: MR-MASH score.
Liver Int
; 44(1): 202-213, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37904633
15.
Circular RNAs in non-alcoholic fatty liver disease: Functions and clinical significance.
RNA Biol
; 21(1): 1-15, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-38113132
16.
The Janus of a disease: Diabetes and metabolic dysfunction-associated fatty liver disease.
Ann Hepatol
; : 101501, 2024 Apr 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38631419
17.
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.
Ann Hepatol
; 29(1): 101133, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-37364816
18.
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease.
JAMA
; 331(15): 1287-1297, 2024 04 16.
Artigo
Inglês
| MEDLINE | ID: mdl-38512249
19.
Chronic liver disease-associated severe thrombocytopenia in Spain: Results from a retrospective study using machine learning and natural language processing.
Gastroenterol Hepatol
; 47(3): 236-245, 2024 Mar.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-37236305
20.
Serum lipidome unravels a diagnostic potential in bile acid diarrhoea.
Gut
; 72(9): 1698-1708, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37072179